about
Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factorsGenomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNAEvolutionary dynamics of HIV at multiple spatial and temporal scales.The dynamic changes of interferon lambdas related genes and proteins in JAK/STAT pathway in both acute and chronic HIV-1 infected patients.NK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaquesToll-like receptor variants are associated with infant HIV-1 acquisition and peak plasma HIV-1 RNA level.Enhanced innate antiviral gene expression, IFN-α, and cytolytic responses are predictive of mucosal immune recovery during simian immunodeficiency virus infection.Progression to AIDS in SIV-Infected Rhesus Macaques is Associated with Distinct KIR and MHC class I Polymorphisms and NK Cell Dysfunction.HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathwaysMechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivoInduction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5.New insights into type I interferon and the immunopathogenesis of persistent viral infections.In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized MiceDisruption of Type I Interferon Induction by HIV Infection of T Cells.Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT miceProduction of interferon α by human immunodeficiency virus type 1 in human plasmacytoid dendritic cells is dependent on induction of autophagyMacroautophagy Regulation during HIV-1 Infection of CD4+ T Cells and Macrophages.HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation.SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosaPegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integrationPersistent LCMV infection is controlled by blockade of type I interferon signaling.Networking at the level of host immunity: immune cell interactions during persistent viral infectionsAntiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.Inhibitory effects of chloroquine on the activation of plasmacytoid dendritic cells in SIVmac239-infected Chinese rhesus macaquesDynamics of innate immunity are key to chronic immune activation in AIDS.Activation of endogenous type I IFN signaling contributes to persistent HCV infection.Immune activation in the central nervous system throughout the course of HIV infection.Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING.Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice.TLR9 and TLR7 agonists mediate distinct type I IFN responses in humans and nonhuman primates in vitro and in vivo.Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy.Innate DNA sensing is impaired in HIV patients and IFI16 expression correlates with chronic immune activation.Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs.Multi-functional plasmacytoid dendritic cells redistribute to gut tissues during simian immunodeficiency virus infection.Immune Checkpoint Inhibitors in Melanoma and HIV Infection.Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection.Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1.
P2860
Q24604018-537EF7F6-88F4-4D78-8C55-49EDC71E716CQ28740542-D3486916-4D87-41D8-A69A-086802294887Q30416280-1ECD410B-7724-409C-AA2F-3B97ECDB1EDAQ33809104-F99D0E7D-48EF-4C54-ABFF-64BB3ADDE789Q33851763-0C8F409D-E073-42B2-9478-6E17B6C2B36AQ34014618-7589D560-A858-49B0-A653-60B47DDC7FF3Q34580079-40D9CEFC-6B4A-4CBD-A526-E6E9BF9DCC9FQ34583325-0083135B-5D66-4D35-8EA4-9D7BBAA9540DQ34889163-D746220A-2FE1-4C16-8085-A5DC7C53D24CQ35012716-D6B08979-EA24-4EEA-9B0B-FD57E8C8DC7AQ35067233-3E49CAFE-C6D4-4D86-B275-9E8DEEB69E5FQ35188470-B0A003D3-1A46-453E-83AF-9AEB83021F97Q35648751-5C181282-115B-4BA0-80B0-C6BD9F2D2A6DQ35760429-18987728-98CC-427F-8055-097475B3A55BQ35777137-0C35111F-9225-4A55-97D1-3FC3959D98F5Q35826239-D82E5E55-8A72-4715-97F2-5CA2AC2EF2F7Q35842310-FFC8EFD9-3449-4B1F-BEB8-BBF31D5F004AQ35939279-96DC5122-0AEC-4C45-B0B7-54C10AC6A4F6Q35970108-D841ABCB-EBC8-4BDC-B317-98FB67C54635Q36486814-F66FCA92-CABF-4582-A689-5C0489CF8B47Q36495526-1CF867A0-CF84-4B1F-830A-0DCA328920A6Q36808119-B8BD1391-4466-4B30-A290-96C51CE51534Q37020616-C3DE149A-B0C9-4FE2-AA02-605FC7E04D3DQ37225169-C00A8CCD-0122-4009-9C6F-46F011226233Q37728049-75D6F224-8D4C-4495-81E5-C43925A9008DQ37966761-90024A4D-0AEC-4D5B-8E37-8BEC33F4C3CEQ38210107-C8395527-6672-4ABB-9307-501D16C910A0Q38694693-4FFD363E-A205-47F6-AB2F-DEA96343C0F2Q38727201-61871C9C-4173-429A-8F41-D52DE4F8822AQ38812549-46ADEDF9-48E4-4017-A773-E6DC9070DE0FQ38962963-8D72AF7F-BE16-44B8-94BC-316F476653ADQ39689723-AE37D39C-CC79-4297-8D6C-B4E490B8E7BCQ40457741-990A8026-1D4C-478F-B779-E2973C089893Q42225763-8D982602-F543-4D28-9E28-47115DDF53EAQ42272761-F31CD0CE-51ED-4F9D-A942-F1AD051C97FDQ45350854-BC51A4CA-65EC-4DD4-9D6D-A8BB8F34BFDEQ47138765-03898FB2-DF60-4F9F-80D7-C05BFE81D462Q47555245-FDB1A678-79E8-4598-8BA9-F342C12AC518Q47586914-FF9D8776-A9ED-4707-A7F0-89645C622367
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Innate immune activation in primary HIV-1 infection.
@ast
Innate immune activation in primary HIV-1 infection.
@en
Innate immune activation in primary HIV-1 infection.
@nl
type
label
Innate immune activation in primary HIV-1 infection.
@ast
Innate immune activation in primary HIV-1 infection.
@en
Innate immune activation in primary HIV-1 infection.
@nl
prefLabel
Innate immune activation in primary HIV-1 infection.
@ast
Innate immune activation in primary HIV-1 infection.
@en
Innate immune activation in primary HIV-1 infection.
@nl
P2860
P356
P1476
Innate immune activation in primary HIV-1 infection.
@en
P2093
J Judy Chang
P2860
P304
P356
10.1086/655657
P407
P478
202 Suppl 2
P577
2010-10-01T00:00:00Z